Bharat Biotech's COVID-19 vaccine Covaxin recommended by expert panel for phase II/III clinical trials on 2 to 18 year-olds: Sources PTI PLB AAR AAR

PTI| New Delhi | India

Updated: 12-05-2021 00:16 IST | Created: 12-05-2021 00:16 IST

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

{{Title}}